share_log

Illumina | 8-K: Current report

Illumina | 8-K: Current report

Illumina | 8-K：重大事件
美股SEC公告 ·  10/04 05:11

Moomoo AI 已提取核心信息

Illumina, Inc., a leading company in the biotechnology sector, has announced a significant change in its executive team. On October 3, 2024, the company disclosed the departure of Charles Dadswell, who served as General Counsel and Secretary. Dadswell will transition to an advisory role, supporting the CEO and Board of Directors until March 31, 2025. Scott Davies, previously Vice President, Legal – Chief Corporate Counsel and Assistant Secretary, has been appointed as the Interim General Counsel and Secretary. The company has entered into an Advisory Agreement with Dadswell, ensuring his advisory services until the end of March 2025, for which he will receive his regular compensation and a lump-sum payment of $600,000 upon completion. Additionally, a Separation Agreement outlines further benefits post-termination, including a lump sum equivalent to his annual salary and extended health insurance coverage.
Illumina, Inc., a leading company in the biotechnology sector, has announced a significant change in its executive team. On October 3, 2024, the company disclosed the departure of Charles Dadswell, who served as General Counsel and Secretary. Dadswell will transition to an advisory role, supporting the CEO and Board of Directors until March 31, 2025. Scott Davies, previously Vice President, Legal – Chief Corporate Counsel and Assistant Secretary, has been appointed as the Interim General Counsel and Secretary. The company has entered into an Advisory Agreement with Dadswell, ensuring his advisory services until the end of March 2025, for which he will receive his regular compensation and a lump-sum payment of $600,000 upon completion. Additionally, a Separation Agreement outlines further benefits post-termination, including a lump sum equivalent to his annual salary and extended health insurance coverage.
生物技术领域领先公司Illumina, Inc.宣布其高管团队发生重大变革。2024年10月3日，公司披露了总法律顾问兼秘书Charles Dadswell的离职。Dadswell将转任顾问职务，支持CEO和董事会直至2025年3月31日。之前担任副总法律顾问兼助理秘书的Scott Davies被任命为临时总法律顾问兼秘书。公司已与Dadswell签订了顾问协议，确保他的顾问服务直至2025年3月底，期间他将获得常规报酬和完成后的60万美元一次性支付。此外，一份分离协议概述了终止后的进一步福利，包括一笔相当于其年薪的一次性支付和延长的健康保险覆盖。
生物技术领域领先公司Illumina, Inc.宣布其高管团队发生重大变革。2024年10月3日，公司披露了总法律顾问兼秘书Charles Dadswell的离职。Dadswell将转任顾问职务，支持CEO和董事会直至2025年3月31日。之前担任副总法律顾问兼助理秘书的Scott Davies被任命为临时总法律顾问兼秘书。公司已与Dadswell签订了顾问协议，确保他的顾问服务直至2025年3月底，期间他将获得常规报酬和完成后的60万美元一次性支付。此外，一份分离协议概述了终止后的进一步福利，包括一笔相当于其年薪的一次性支付和延长的健康保险覆盖。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间